I really don’t understand how this is only worth $50m.
With Bisantrene’s proven history of working, the market potential, the solid team on deck to get modern trials and evidence under way, probable PRV voucher with a value north of $80-$100m, and other phase 2/3 peers with no where as near potential trading at over $200m market cap, I can see this going north of $100m in the next 6 months and long term target of $200m-$250m once the trials kick off.
Just my opinion.
I really don’t understand how this is only worth $50m. With...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.22 |
Change
0.030(2.52%) |
Mkt cap ! $202.7M | |||
| Open | High | Low | Value | Volume |
| $1.22 | $1.22 | $1.16 | $78.70K | 66.45K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $1.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.22 | 4561 | 1 |
View Market Depth
| Last trade - 16.10pm 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.19 |
Change
0.030 ( 0.42 %) |
||||
| Open | High | Low | Volume | ||
| $1.19 | $1.22 | $1.16 | 11297 | ||
| Last updated 15.56pm 07/05/2024 ? | |||||
| RAC (ASX) Chart |